2022
Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials
Friedman DJ, Du C, Wang Y, Agarwal V, Varosy PD, Masoudi FA, Holmes DR, Reddy VY, Price MJ, Curtis JP, Freeman JV. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials. JACC Cardiovascular Interventions 2022, 15: 950-961. PMID: 35512918, PMCID: PMC9370831, DOI: 10.1016/j.jcin.2022.02.029.Peer-Reviewed Original ResearchConceptsRegistry patientsHemorrhagic stroke riskIschemic strokeWarfarin patientsTrial patientsStroke riskLAAO patientsClinical practiceMore pericardial effusionsPeriprocedural ischemic strokePropensity-matched analysisAtrial appendage occlusionCox proportional hazardsPatient-level dataFine-Gray modelMore comorbiditiesPROTECT AFNoncardiovascular deathPericardial effusionHemorrhagic strokeAppendage occlusionDevice implantationTrial criteriaClinical trialsSimilar riskPeriprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry
Price MJ, Valderrábano M, Zimmerman S, Friedman DJ, Kar S, Curtis JP, Masoudi FA, Freeman JV. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry. Circulation Cardiovascular Interventions 2022, 15: e011718. PMID: 35369701, PMCID: PMC9132377, DOI: 10.1161/circinterventions.121.011718.Peer-Reviewed Original ResearchConceptsAtrial appendage occlusionComposite of deathPericardial effusionAppendage occlusionSystemic embolismOdds ratioEarly postdischarge mortalityDual antiplatelet therapyLow serum albuminMean patient ageAdverse event ratesParoxysmal atrial fibrillationRisk of deathRisk-benefit ratioHospital strokeMean CHAPostdischarge mortalityVASc scoreWATCHMAN procedureAntiplatelet therapyIndex hospitalizationAdverse eventsPatient agePrimary outcomeVentricular function
2012
Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies.
Tavris DR, Wang Y, Jacobs S, Gallauresi B, Curtis J, Messenger J, Resnic FS, Fitzgerald S. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies. Journal Of Invasive Cardiology 2012, 24: 328-34. PMID: 22781471.Peer-Reviewed Original ResearchConceptsVascular closure deviceFemoral access siteHemostasis strategyPercutaneous coronary interventionVascular complicationsComplication rateSafety profileAccess siteHierarchical multiple logistic regression analysisMultiple logistic regression analysisPercutaneous coronary intervention (PCI) proceduresVascular complication ratesReduced complication ratesGood safety profileFemoral artery occlusionCoronary intervention proceduresRepresentative observational studyLogistic regression analysisRegression analysisType of hemostasisArtery dissectionCathPCI RegistryArtery occlusionCardiac catheterizationCoronary intervention
2008
Distal Embolic Protection During Renal Artery Stenting: Impact on Hypertensive Patients With Renal Dysfunction
Singer GM, Setaro JF, Curtis JP, Remetz MS. Distal Embolic Protection During Renal Artery Stenting: Impact on Hypertensive Patients With Renal Dysfunction. Journal Of Clinical Hypertension 2008, 10: 830-836. PMID: 19128271, PMCID: PMC8672993, DOI: 10.1111/j.1751-7176.2008.00030.x.Peer-Reviewed Original ResearchConceptsDistal embolic protectionChronic kidney diseaseBlood pressureRenal arteryHypertensive patientsEmbolic protectionDEP patientsRenal artery stentingSystolic BP reductionGlomerular filtration rateSystolic blood pressureBP reductionEGFR improvementRenal dysfunctionArtery stentingKidney diseaseFiltration rateAtherosclerotic debrisPatientsArteryMonthsEGFRBaselineHypertensionEmbolization